LivaNova (LIVN) Cash & Equivalents Growth (1y) (2015 - 2026)
LivaNova (LIVN) Cash & Equivalents Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | -26.57% |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 42.78% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | -12.13% |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 0.94% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -11.19% |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | -4.66% |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | -44.03% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 19.49% |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 72.43% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | -12.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.97% |
| Mar 31, 2026 | -26.91% |
| Dec 31, 2025 | 48.20% |
| Mar 31, 2025 | 140.93% |
| Dec 31, 2024 | 37.73% |
| Sep 30, 2024 | 15.92% |
| Jun 30, 2024 | -2.42% |
| Mar 31, 2024 | -0.68% |
| Dec 31, 2023 | 3.29% |
| Sep 30, 2023 | 8.58% |
| Jun 30, 2023 | 4.59% |
| Mar 31, 2023 | -1.59% |
| Sep 30, 2022 | 51.34% |
| Jun 30, 2022 | -9.61% |
| Mar 31, 2022 | 24.18% |
| Sep 30, 2021 | -20.18% |
| Jun 30, 2021 | 41.64% |
| Mar 31, 2021 | 100.71% |
| Dec 31, 2020 | 313.55% |
| Sep 30, 2020 | 202.49% |